AdvanSix (ASIX) to Release Quarterly Earnings on Friday

AdvanSix (NYSE:ASIXGet Free Report) is anticipated to release its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect AdvanSix to post earnings of $0.40 per share and revenue of $365.00 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Friday, November 7, 2025 at 9:30 AM ET.

AdvanSix Trading Down 0.7%

Shares of AdvanSix stock opened at $18.61 on Wednesday. AdvanSix has a 12-month low of $17.97 and a 12-month high of $33.00. The company has a market cap of $499.39 million, a price-to-earnings ratio of 6.55 and a beta of 1.72. The company has a current ratio of 1.35, a quick ratio of 0.66 and a debt-to-equity ratio of 0.29. The company’s 50-day moving average price is $20.14 and its 200-day moving average price is $21.61.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ASIX shares. Wall Street Zen cut shares of AdvanSix from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of AdvanSix in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $33.50.

Read Our Latest Report on ASIX

Institutional Trading of AdvanSix

Institutional investors and hedge funds have recently made changes to their positions in the stock. Raymond James Financial Inc. purchased a new stake in AdvanSix during the second quarter valued at about $29,000. Osaic Holdings Inc. raised its position in AdvanSix by 60.2% during the second quarter. Osaic Holdings Inc. now owns 1,285 shares of the company’s stock valued at $31,000 after purchasing an additional 483 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of AdvanSix by 144.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,385 shares of the company’s stock valued at $57,000 after buying an additional 1,408 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of AdvanSix by 8.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,862 shares of the company’s stock valued at $234,000 after buying an additional 746 shares in the last quarter. Finally, Creative Planning raised its holdings in shares of AdvanSix by 13.2% during the 2nd quarter. Creative Planning now owns 11,961 shares of the company’s stock valued at $284,000 after buying an additional 1,399 shares in the last quarter. Hedge funds and other institutional investors own 86.39% of the company’s stock.

About AdvanSix

(Get Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Further Reading

Earnings History for AdvanSix (NYSE:ASIX)

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.